• KU-55933: ATM Kinase Inhibition Unveils Metabolic Vulnera...

  2025-10-19

  Explore how KU-55933, a potent ATM kinase inhibitor, drives innovation in DNA damage response research by revealing metabolic vulnerabilities in cancer cells. This article uniquely connects ATM signaling, cell cycle arrest, and metabolic reprogramming, offering fresh insights for advanced cancer and rare disease applications.

• KU-60019: Unlocking Metabolic Vulnerabilities in Glioma v...

  2025-10-18

  Discover how KU-60019, a selective ATM kinase inhibitor, unveils novel metabolic vulnerabilities in glioma by integrating DNA damage response inhibition with advanced metabolic reprogramming. This article offers a unique framework for leveraging KU-60019 in cancer research beyond radiosensitization.

242 records 17/17 page Previous First page 上5页 1617